BioMarin to Attend Upcoming Investor Conferences
31 August 2016 - 10:30PM
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), today announced that
management will participate in the Gene Therapy Panel at Citi’s
11th Annual Biotech Conference on September 7, 2016 at 1:00pm ET in
Boston, the Robert W. Baird & Co. 2016 Global Healthcare
Conference September 8, 2016 at 9:40am ET in New York and the
Leerink Partners Roundtable Series: Rare Disease and
Immuno-Oncology on September 28, 2016 at 10:00am ET in New
York. To access the live webcasts, please visit the investor
section of the BioMarin website, www.biomarin.com. A replay
will also be archived on the site for at least one week following
the event.
About BioMarin
BioMarin is a global biotechnology company that
develops and commercializes innovative therapies for people with
serious and life-threatening rare disorders. The company's
portfolio consists of five commercialized products and multiple
clinical and pre-clinical product candidates.
For additional information, please visit
www.biomarin.com. Information on BioMarin's website is not
incorporated by reference into this press release.
Contacts:
Investors
Traci McCarty
BioMarin Pharmaceutical Inc.
(415) 455-7558
Media
Debra Charlesworth
BioMarin Pharmaceutical Inc.
(415) 455-7451
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Apr 2024 to May 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From May 2023 to May 2024